Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
HPV Self-Collection
Hospital Authority, Hong Kong
Cervical Cancers
1 trial -
Hypervision proton surgery
Hospital Authority, Hong Kong
Non-Small Cell Lung Cancer
1 trial -
Hypofractionated Radiation Therapy
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Hypofractionated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Immediate CEUS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cancer
1 trial -
Intraoperative identification method
Xijing Hospital
Thyroid Cancer
1 trial -
Irinotecan Hydrochloride Liposome Injection๏ผCarboplatin Injection๏ผSerplulimab Injection
The First People's Hospital of Lianyungang
Small Cell Lung Cancer
1 trial -
LCI+white light
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Early Gastric Cancer
1 trial -
Lidocaine Hydrochloride 2% Injection Solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Lidocaine Hydrochloride, Injectable
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Liver Cancer
1 trial -
Lidocaine IV
Samsung Bioepis NL B.V.
Colorectal Cancer
1 trial -
Linked Color Imaging
Hospital Authority, Hong Kong
Early Gastric Cancer
1 trial -
Liposomal Doxorubicin
United Therapeutics Europe Ltd
Ovarian Cancer
1 trial -
Liquid Biopsy (SPOT-MAS Assay)
Hospital Authority, Hong Kong
Lung Cancer
1 trial -
Liquid Biopsy Early Screening
The First People's Hospital of Lianyungang
Liquid Biopsy for Early Screening of Lung Cancer
1 trial -
MR/PET
Hospital Authority, Hong Kong
Non-small Cell Lung Cancer
1 trial -
MV-PRS Sub-study
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Metformin
The First People's Hospital of Lianyungang
Endometrial Cancer
1 trial -
Metoclopramide 10mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Oral Cancer
1 trial -
Nab-paclitaxel
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Next generation sequencing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Cancer
1 trial -
Nutrition Intervention
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Nutritional therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer
1 trial -
POHIM-RT
Samsung Bioepis NL B.V.
Cervix Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources